Vázquez Morón JM - Search Results

1

The onset of ulcerative colitis during treatment with secukinumab: can anti-IL-17A be a trigger for inflammatory bowel disease?

Rodríguez Moncada R, Vázquez Morón JM, Pallarés Manrique H. Rodríguez Moncada R, et al. Among authors: vazquez moron jm. Rev Esp Enferm Dig. 2019 Sep;111(9):720-721. doi: 10.17235/reed.2019.5841/2018. Rev Esp Enferm Dig. 2019. PMID: 31333036 Free article. Review.

2

Crohn's-like disease in a patient with common variable immunodeficiency treated with azathioprine and adalimumab.

Vázquez-Morón JM, Pallarés-Manrique H, Martín-Suárez IJ, Benítez-Rodríguez B, Ramos-Lora M. Vázquez-Morón JM, et al. Rev Esp Enferm Dig. 2013 May-Jun;105(5):299-302. doi: 10.4321/s1130-01082013000500010. Rev Esp Enferm Dig. 2013. PMID: 23971663 Free article.

3

Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.

Moreno-Rincón E, Benítez JM, Serrano-Ruiz FJ, Vázquez-Morón JM, Pallarés-Manrique H, Herrera-Justiniano JM, Leo-Carnerero E, Gómez-García MR, Cabello-Tapia MJ, Castro-Fernández M, Rojas-Feria M, Castro-Laria L, Argüelles-Arias F, Camargo-Camero R, Alcaín-Martínez G, Iglesias-Flores E, García-Sánchez V. Moreno-Rincón E, et al. Among authors: vazquez moron jm. Inflamm Bowel Dis. 2015 Jul;21(7):1564-71. doi: 10.1097/MIB.0000000000000400. Inflamm Bowel Dis. 2015. PMID: 26070002

4

Accurate cut-offs for predicting endoscopic activity and mucosal healing in Crohn's disease with fecal calprotectin.

Vázquez Morón JM, Pallarés Manrique H, Machancoses FH, Ramos Lora M, Ruiz Frutos C. Vázquez Morón JM, et al. Rev Esp Enferm Dig. 2017 Feb;109(2):130-136. doi: 10.17235/reed.2017.4542/2016. Rev Esp Enferm Dig. 2017. PMID: 28071062 Free article.

5

Managing iron deficiency and iron deficiency anemia in inflammatory bowel disease. The results of the "Gestiona hierro-EII" survey.

Casellas Jordá F, Vera Mendoza I, Barreiro-de Acosta M, Vázquez Morón JM, López Román J, Júdez Gutiérrez J. Casellas Jordá F, et al. Among authors: vazquez moron jm. Rev Esp Enferm Dig. 2018 Mar;110(3):172-178. doi: 10.17235/reed.2018.5354/2017. Rev Esp Enferm Dig. 2018. PMID: 29465251 Free article.

6

Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: results of a multicenter study after 12 months.

Guerra Veloz MF, Vázquez Morón JM, Belvis Jiménez M, Pallarés Manrique H, Valdés Delgado T, Castro Laria L, Maldonado Pérez B, Benítez Roldán A, Perea Amarillo R, Merino V, Caunedo Álvarez Á, Argüelles Arias F. Guerra Veloz MF, et al. Among authors: vazquez moron jm. Rev Esp Enferm Dig. 2018 Sep;110(9):564-570. doi: 10.17235/reed.2018.5368/2017. Rev Esp Enferm Dig. 2018. PMID: 29893581 Free article.

7

Intravenous ustekinumab reinduction as a Crohn's disease rescue strategy following a secondary non-response.

Vázquez Morón JM, Rodríguez Moncada R, Pallarés Manrique H. Vázquez Morón JM, et al. Rev Esp Enferm Dig. 2019 Sep;111(9):721. doi: 10.17235/reed.2019.5802/2018. Rev Esp Enferm Dig. 2019. PMID: 31333034 Free article.

8

Ustekinumab in Crohn's disease: real-world outcomes and predictors of response.

Lorenzo González L, Valdés Delgado T, Vázquez Morón JM, Castro Laria L, Leo Carnerero E, Maldonado Pérez MB, Sánchez Capilla D, Pallarés Manrique H, Sáez Díaz A, Argüelles Arias F; Grupo de Enfermedad Inflamatoria de Andalucía. Lorenzo González L, et al. Among authors: vazquez moron jm. Rev Esp Enferm Dig. 2022 May;114(5):272-279. doi: 10.17235/reed.2020.7352/2020. Rev Esp Enferm Dig. 2022. PMID: 33393332 Free article.

9

Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia.

Hernández Martínez A, Navajas Hernández P, Martín Rodríguez MDM, Lázaro Sáez M, Olmedo Martín R, Núñez Ortiz A, Argüelles Arias F, Fernández Cano MC, Gallardo Sánchez F, Marín Pedrosa S, González García J, Vázquez Morón JM. Hernández Martínez A, et al. Among authors: vazquez moron jm. Rev Esp Enferm Dig. 2022 Sep;114(9):516-521. doi: 10.17235/reed.2022.8380/2021. Rev Esp Enferm Dig. 2022. PMID: 35000397 Free article.

10

Effectiveness and safety of ustekinumab dose escalation in Crohn's disease: a multicenter observational study.

Olmedo Martín RV, Vázquez Morón JM, Martín Rodríguez MDM, Lázaro Sáez M, Hernández Martínez Á, Argüelles-Arias F. Olmedo Martín RV, et al. Among authors: vazquez moron jm. Rev Esp Enferm Dig. 2023 Dec;115(12):686-692. doi: 10.17235/reed.2023.9402/2022. Rev Esp Enferm Dig. 2023. PMID: 37314131 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page